tiprankstipranks
Advertisement
Advertisement
Veracyte announces U.S. commercial launch of Prosigna ROR test
PremiumThe FlyVeracyte announces U.S. commercial launch of Prosigna ROR test
1M ago
Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting
Premium
The Fly
Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting
1M ago
Veracyte Oncology Portfolio Progress Supports Buy Rating and Unchanged $48 Price Target
Premium
Ratings
Veracyte Oncology Portfolio Progress Supports Buy Rating and Unchanged $48 Price Target
1M ago
Veracyte Inc Earnings Call Signals Profitable Growth
PremiumCompany AnnouncementsVeracyte Inc Earnings Call Signals Profitable Growth
2M ago
Veracyte Inc (VCYT) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Veracyte Inc (VCYT) Q1 Earnings Cheat Sheet
2M ago
Veracyte announces new data at AUA 2026 on Decipher portfolio
Premium
The Fly
Veracyte announces new data at AUA 2026 on Decipher portfolio
2M ago
Veracyte Appoints Kevin Haas as Chief Technology Leader
PremiumCompany AnnouncementsVeracyte Appoints Kevin Haas as Chief Technology Leader
4M ago
Veracyte names Kevin Haas as Chief Development and Technology Officer
Premium
The Fly
Veracyte names Kevin Haas as Chief Development and Technology Officer
4M ago
Veracyte price target lowered to $37 from $48 at Morgan Stanley
Premium
The Fly
Veracyte price target lowered to $37 from $48 at Morgan Stanley
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100